Medispec's Launches a Desktop Version of Its Innovative Erectile Dysfunction System, ED1000. Utilizing this innovative compact system, physicians can now easily offer Medispec's revolutionary non-invasive treatment anywhere
February 3, 2014 (Newswire) - Medispec, a world leader in non-invasive medical solutions, has launched its ED-1000 Desktop system for treating Erectile Dysfunction (ED). ED-1000 Desktop is designed based on Medispec's accumulated experience and expertise, enabling physicians to extend treatment availability to additional small facilities, and at home treatments. In numerous cultures and countries ED treatment is considered a cause for embarrassment for men.
Enabling physicians to attend to patients after clinic hours is now easy, as the physician can carry the modular system from the clinic with him and treat patients at the privacy of their homes. ED-1000 Desktop is light weighted (12Kg), modular and mobile, yet offers the same clinical advantages of the company's successful ED-1000 system.
ED-1000 offers a pain-free treatment that for significant long-term improvement in sexual performance of men suffering from ED. It utilizes non-invasive shockwave therapy to trigger the body's natural repair mechanism, successfully treating the underlying cause of ED and not merely its symptoms. The treatment is safe, fast and completely free of side effects. The solution is also beneficial for patients who have not responded well to pharmacological alternatives, and treatment cost is comparable to that of a standard drug regimen, with the added benefit of long-term results.
Since the launch of the ED-1000 system, it has demonstrated enormous success across the world, with outstanding results in over 30 countries, including the UK, Spain, Greece, Japan, Korea, HK, Canada, and more. In the US, the ED-1000 is limited to investigational use.
Recently, the European Association of Urology (EAU) has officially accepted Low Intensity Shock Wave Therapy (EDSWT) as the gold standard for treatments of Erectile Dysfunction in the EAU 2013 guidelines on Male Sexual Dysfunction. This was based on clinical trials using Medispec's ED1000.
In order to extend the reach of this innovative treatment to additional medical facilities and offer treatment to patients who are reluctant to receive such treatment in public facilities, Medispec has designed a compact and mobile desktop version of this successful system. The system is already commercially available in different countries such as Turkey, Japan and India.
For additional information about ED-1000 Desktop, ED-1000, and Medispec, please contact us at firstname.lastname@example.org.